MARD RANGE OF GUESSING BLOOD GLUCOSE VALUES IN PEOPLE WITH T1DM

被引：0
|
作者：
Budiman, E. [1 ]
机构：
[1] Abbott Diabet Care, Alameda, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
175
引用
收藏
页码：A70 / A71
页数：2
相关论文
共 50 条
  • [31] Cardiovascular benefits of metformin in T1DM
    Janet K. Snell-Bergeon
    Nature Reviews Endocrinology, 2017, 13 : 565 - 566
  • [32] Emerging Roles of Exosomes in T1DM
    Pang, Haipeng
    Luo, Shuoming
    Xiao, Yang
    Xia, Ying
    Li, Xia
    Huang, Gan
    Xie, Zhiguo
    Zhou, Zhiguang
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [33] Risk of kidney disease in T1DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (12) : 689 - 689
  • [34] LIPOPEROXIDATION IS NEGATIVELY ASSOCIATED WITH VASCULAR FUNCTION IN T1DM BUT NOT WITH GLUCOSE CONTROL OR VARIABILITY
    Prazny, M.
    Skrha, J., Jr.
    Pelcl, T.
    Flekac, M.
    Kacer, P.
    Skrha, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A146 - A147
  • [35] Immunotherapy for T1DM—still not there yet
    Raffaella Buzzetti
    Nature Reviews Endocrinology, 2013, 9 : 697 - 698
  • [36] Innate cell crosstalk in T1DM
    Carol Wilson
    Nature Reviews Endocrinology, 2013, 9 (3) : 127 - 127
  • [37] The largest study of genetics of T1DM
    Starling S.
    Nature Reviews Endocrinology, 2021, 17 (9) : 515 - 515
  • [38] Is the Dawn Phenomenon Predictable in T1DM?
    Bouchonville, Matthew
    Duran-Valdez, Elizabeth
    Schade, David S.
    DIABETES, 2013, 62 : A44 - A45
  • [39] THERAPY Immunotherapy advance for T1DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (10) : 564 - 564
  • [40] T1DM incidence trends in Europe
    Carol Wilson
    Nature Reviews Endocrinology, 2012, 8 (8) : 446 - 446
12345